Iron sucrose (Venofer)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 00:59, 29 June 2024 by Warner-admin (talk | contribs) (Text replacement - "please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [https://online.lexi.com/lco/action/login UpToDate Lexidrug], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information" to "please refer to your preferred pharmacopeias or the prescribing information")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

General information

Class/mechanism: Iron, which is needed for various biologic processes, including synthesis of hemoglobin and multiple enzymatic processes.[1][2][3]
Route: IV
Extravasation: no information

  • 1 mL of Venofer provides 20 mg of elemental iron

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.[1]

Patient drug information

History of changes in FDA indication

  • 2000-11-06: Approved for the treatment of iron deficiency anemia in patients with chronic kidney disease (CKD).

Also known as

  • Brand name: Venofer

References